This webinar discusses emerging biomarkers for thyroid cancer and non-small cell lung cancer, with a particular focus on detecting gene fusions such as RET.

Our speaker, Dr. Sandip Patel of UCSD,  provides an overview of biomarker-guided therapies for thyroid cancer and NSCLC and will discuss key emerging biomarkers for these indications along with their supporting evidence.

Dr. Patel also discusses different biomarker testing approaches, practical considerations, and address challenges around fusion detection.

The webinar highlights hybrid-capture based comprehensive genomic profiling as a preferred method, along with a background and overview of this approach.

Sandip Patel, MD
Medical Oncologist
Associate Professor

Fill Out Form to Access Webinar

Your email address is never shared with third parties.

Date & Time
Dec 9, 2019
10:00 AM
Oncology, Cancer research
Watch Now